We play a leading role in the prevention and reduction of cardiovascular diseases, in particular heart disease and stroke.
Europe’s Cardiovascular Health Opportunities:
Leadership for Change
EHN has members across Europe. EHN members are national heart foundations and associations committed to preventing cardiovascular disease (CVD) in Europe, supporting patients, representing patient interests and funding research.
“Vision to policy: Cardiovascular Health 12 months on”
From 11 to 15 December in Strasbourg
We believe every European has a right to a life free from avoidable cardiovascular diseases. We play a leading role in the prevention and reduction of cardiovascular diseases, through advocacy, networking, capacity-building, representing patient interests and research.
Deaths for CVD in Europe per year
Of all deaths in Europe are from CVD
Annual cost of CVD to EU economy (€)
People living with CVD in Europe
A greater reduction of exposure to the main risk factors for CVD would increase the number of years lived in good health.
EHN works on EU policy files related to issues that affect patients with cardiovascular disease.
EHN facilitates networking and exchange between its research-funding members, gathered in the EHN Research Platform, as well as their interaction with members of the EHN’s Patient Group.
EHN facilitates meaningful and structured patient involvement in projects to enable patients to be active partners in creating person-centred cardiovascular research and innovation.
29 Sep 2023
The upcoming EACH Summit, “Vision to policy: Cardiovascular Health 12 months on” will take place from 11 to 15...
Brussels, 29 September 2023: Cardiovascular disease (CVD) is the leading cause of death globally and costs the EU...
28 Sep 2023
The first AI4HF project workshop with patients with heart failure (HF) was co-organised by the European Heart Network...